当前位置: 首页 >> 检索结果
共有 4690 条符合本次的查询结果, 用时 2.062731 秒

4301. Rising Incidence of Cancer of the Small Intestine: Overdiagnosis and Better Diagnosis of Low-lethality Disease.

作者: Haley Yao.;Claire Sokas.;H Gilbert Welch.
来源: Gastroenterology. 2022年162卷6期1749-1751.e2页

4302. The Role of Carboxymethylcellulose in Health and Disease: Is the Plot Thickening?

作者: Judith Wellens.;Séverine Vermeire.;João Sabino.
来源: Gastroenterology. 2022年163卷3期780-781页

4303. Failure to Achieve Target Drug Concentrations During Induction and Not HLA-DQA1∗05 Carriage Is Associated With Antidrug Antibody Formation in Patients With Inflammatory Bowel Disease.

作者: Elizabeth A Spencer.;Jordan Stachelski.;Thierry Dervieux.;Marla C Dubinsky.
来源: Gastroenterology. 2022年162卷6期1746-1748.e3页

4304. Reply.

作者: Sandra Nagl.;Alanna Ebigbo.;Helmut Messmann.
来源: Gastroenterology. 2022年162卷6期1777-1778页

4305. Association between the cardiometabolic index and non-alcoholic fatty liver disease: insights from a general population.

作者: Jiawang Zou.;Hailan Xiong.;Huimin Zhang.;Chong Hu.;Song Lu.;Yang Zou.
来源: BMC Gastroenterol. 2022年22卷1期20页
Emerging evidence suggests that cardiometabolic index (CMI) is closely related to diabetes, hypertension, stroke, cardiovascular disease, and kidney disease, which implies that CMI has the value as an indicator of metabolic diseases. However, data on the relationships between CMI and non-alcoholic fatty liver disease (NAFLD) risks have not been reported. This study is designed to examine the association between CMI and NAFLD in the general population.

4306. Delayed diagnosis and subsequently increased severity of acute appendicitis (compatible with clinical-pathologic grounds) during the COVID-19 pandemic: an observational case-control study.

作者: Amitai Bickel.;Samer Ganam.;Ibrahim Abu Shakra.;Inbal Farkash.;Rola Francis.;Nour Karra.;Fahed Merei.;Isaac Cohen.;Eli Kakiashvili.
来源: BMC Gastroenterol. 2022年22卷1期19页
During a global crisis like the current COVID-19 pandemic, delayed admission to hospital in cases of emergent medical illness may lead to serious adverse consequences. We aimed to determine whether such delayed admission affected the severity of an inflammatory process regarding acute appendicitis, and its convalescence.

4307. The effect of group-based education on gastrointestinal symptoms and quality of life in patients with celiac disease: randomized controlled clinical trial.

作者: Zahra Akbari Namvar.;Reza Mahdavi.;Masood Shirmohammadi.;Zeinab Nikniaz.
来源: BMC Gastroenterol. 2022年22卷1期18页
In this trial, we investigated the effect of a group-based education program on gastrointestinal (GI) symptoms and quality of life (QOL) in patients with celiac disease (CD).

4308. A case for improved assessment of gut permeability: a meta-analysis quantifying the lactulose:mannitol ratio in coeliac and Crohn's disease.

作者: Jonathan Gan.;Scarlet Nazarian.;Julian Teare.;Ara Darzi.;Hutan Ashrafian.;Alex J Thompson.
来源: BMC Gastroenterol. 2022年22卷1期16页
A widely used method in assessing small bowel permeability is the lactulose:mannitol test, where the lactulose:mannitol ratio (LMR) is measured. However, there is discrepancy in how the test is conducted and in the values of LMR obtained across studies. This meta-analysis aims to determine LMR in healthy subjects, coeliac and Crohn's disease.

4309. Combined therapy with early initiation of infliximab following drainage of perianal fistulising Crohn's disease: a retrospective cohort study.

作者: Ping Zhu.;Jin-Fang Sun.;Yun-Fei Gu.;Hong-Jin Chen.;Min-Min Xu.;You-Ran Li.;Bo-Lin Yang.
来源: BMC Gastroenterol. 2022年22卷1期15页
Recent studies have confirmed that combined surgery and anti-TNF therapy could improve outcomes in patients with perianal fistulising Crohn's disease (PFCD). However, the optimal timing for infliximab infusion after surgical intervention is uncertain. We aimed to determine the long-term efficacy of early initiation of infliximab following surgery among PFCD patients.

4310. Complete pathological response of colorectal peritoneal metastases in Lynch syndrome after immunotherapy case report: is a paradigm shift in cytoreductive surgery needed?

作者: Marco Tonello.;Floriana Nappo.;Loretta Vassallo.;Rosa Di Gaetano.;Carla Davoli.;Elisa Pizzolato.;Ottavia De Simoni.;Cristina Tassinari.;Antonio Scapinello.;Pierluigi Pilati.;Fotios Loupakis.;Sara Lonardi.;Antonio Sommariva.
来源: BMC Gastroenterol. 2022年22卷1期17页
We report the first case of a patient affected by peritoneal metastases from colon cancer, arising in the context of Lynch syndrome with pathological complete response. The patient was treated with immunotherapy and cytoreductive surgery. This paper discusses the implications of these novel therapies for the management of PM.

4311. Genetic Variation in Sugar Metabolism Confers a Protective Metabolic Profile.

作者: Johnny Le.;Cholsoon Jang.
来源: Gastroenterology. 2022年162卷4期1033-1035页

4312. Achieving Health Equity Through Digestive Diseases Research and Scientific Workforce Diversity.

作者: Megan E Singh.;Stephen P James.;Gregory G Germino.;Griffin P Rodgers.
来源: Gastroenterology. 2022年162卷6期1597-1601.e1页

4313. Early Life: An Important Window of Susceptibility for Colorectal Cancer.

作者: Caitlin C Murphy.;Barbara A Cohn.
来源: Gastroenterology. 2022年163卷2期532-533页

4314. Prevalence and Predictors of Young-Onset Colorectal Neoplasia: Insights From a Nationally Representative Colonoscopy Registry.

作者: Parth D Trivedi.;Aditi Mohapatra.;Melissa K Morris.;Shannon A Thorne.;Sandy C Smith.;Amanda M Ward.;Paul Schroy.;Heather Hampel.;Lina Jandorf.;John W Popp.;Steven H Itzkowitz.
来源: Gastroenterology. 2022年162卷4期1136-1146.e5页
A disturbing increase in early-onset colorectal cancer (EOCRC) has prompted recent guidelines to recommend lowering the colorectal cancer (CRC) screening starting age from 50 to 45 years old for average-risk individuals. Little is known about the prevalence of colorectal neoplasia in individuals between 45 and 49 years old, or even younger, in the United States. We analyzed a large, nationally representative data set of almost 3 million outpatient colonoscopies to determine the prevalence of, and risk factors for, colorectal neoplasia among patients aged 18 to 54.

4315. Local health company 3 Liguria (ASL3) introduces the GLU GLU test for alcohol use disorder identification.

作者: Patrizia Balbinot.;Luigi C Bottaro.;Rinaldo Pellicano.;Gianni Testino.
来源: Minerva Gastroenterol (Torino). 2022年68卷2期234-235页

4316. Severe autoimmune hepatitis following recovery from COVID-19: a novel mode of liver injury triggered by SARS-COV-2?

作者: Adam Folman.;Helal Said-Ahmad.;Amir Mari.;Tarek Saadi.;Ella Veitsman.;Afif Yaccob.
来源: Minerva Gastroenterol (Torino). 2022年68卷3期334-336页

4317. Diarrhea due to parasites: a short, updated point of view from the clinical setting.

作者: Anna Mauriello.;Amir Mari.;William Nseir.;Giorgio M Saracco.;Rinaldo Pellicano.
来源: Minerva Gastroenterol (Torino). 2022年68卷4期463-469页
Diarrhea represents a common manifestation of several gastrointestinal diseases. Infectious agents are the most common causes of diarrhea in developing countries, where the inadequate sanitation and hygiene are prevalent. In these countries, the scarcity of preventive measures as well as the limited health resources cause a substantial increase in incidence, morbidity and mortality due to infectious diseases, including diarrhea. Currently, with the availability of rapid and inexpensive air transportation millions of people travel for tourism, work and immigration from developing countries to industrialized countries and vice versa. This leads to a high number of imported pathogens such as parasites causing infectious diarrhea. Importantly, while most cases of parasitic diarrhea are short, mild and self-limited, other cases may be associated with chronic diarrhea and serious morbidity and mortality. The aim of the current review was to provide an update, from a clinician's point of view, of the main parasites causing diarrhea, with a focus on their diagnosis and management in the clinical setting.

4318. Iodide mumps in a patient with liver cirrhosis without renal impairment.

作者: Federica Fimiano.;Rinaldo Pellicano.;Alfredo Marzano.
来源: Minerva Gastroenterol (Torino). 2022年68卷4期482-484页
Salivary gland enlargement following iodine-containing contrast media (ICCM), also known as iodide mumps (IM), is a rare condition characterized by swelling of submandibular glands with complete restitutio ad integrum. It manifests itself without pain, fever, dyspnea, rapid heart rate or low blood pressure. The pathogenesis is unknown, it may be an idiosyncratic reaction or toxic due to deposition of iodide in the salivary glands. IM is a condition more frequent in end stage renal disease because of iodine excretion by kidneys but it can also occur in patients without end stage renal disease. In this study, we described a 71-year-old patient with liver cirrhosis due to hepatitis B virus with normal renal function that after administration of ICCM developed IM.

4319. Study on the effect of path-based pain nursing on the rehabilitation of patients after hepatobiliary operation.

作者: Wei Sun.;Xiaoping Xu.;Min Zhao.;Donge Duan.;Min Xiong.;Xiangqun Peng.
来源: Minerva Gastroenterol (Torino). 2022年68卷3期354-356页

4320. Probiotics in the treatment of Helicobacter pylori infection: reality and perspective.

作者: Guzel Isaeva.;Regina Isaeva.
来源: Minerva Gastroenterol (Torino). 2022年68卷3期277-288页
Helicobacter pylori (H. pylori) infection is one of the most common in the world today, associated with the development of acute or chronic inflammatory diseases of the gastroduodenal tract. In order to eradicate the pathogen, various antibacterial therapy regimens have been proposed, based on the use of several chemotherapeutic drugs and a proton pump inhibitor (PPI). However, recent studies indicate a decrease in antibiotic effectiveness due to both the growth rate of H. pylori resistance and side effects, often due to the development of dysbiosis. One of the promising areas of investigation is the treatment with probiotic therapy of helicobacteriosis. The use of probiotics, in the context of H. pylori infection, has two main reasons. The first is related to the use of certain probiotics to reduce the frequency of undesirable gastrointestinal consequences during H. pylori eradication therapy. The second is associated with the antagonistic effect of individual probiotics on H. pylori and the potentiation of the eradication effect. The purpose of this review was to summarize the latest data on the use of probiotics to enhance H. pylori eradication and to restore the gastrointestinal microbiota. Many unresolved questions, about the choice of the specific composition of the probiotic cocktail, dosage, duration of therapy, mechanisms of the antimicrobial action of probiotics, as well as possible negative consequences of such therapy, remain.
共有 4690 条符合本次的查询结果, 用时 2.062731 秒